Last edition
News about "Deciphera Pharmaceuticals "
UK MHRA Approves Vimseltinib for Tenosynovial Giant Cell Tumours
UK MHRA approves Deciphera Pharma’s vimseltinib for adults with tenosynovial giant cell tumours affecting movement or where surgery is not an option.
Deciphera Pharmaceuticals | 18/08/2026 | By News Bureau
Ono Announces Acquisition of Deciphera Pharmaceuticals
Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.
Deciphera Pharmaceuticals | 14/06/2024 | By Aishwarya | 837
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy